Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKore Potash PLC Regulatory News (KP2)

Share Price Information for Kore Potash PLC (KP2)

Share Price is delayed by 15 minutes
Get Live Data
2.90    0.00 (0.00%)
Bid:
2.80
Ask:
3.00
Spread: 0.20 (7.143%)
Market Cap: £150.10m
KP2 Live PriceLast checked at - London Stock Exchange

Intraday Kore Potash PLC Share Chart

CDI Monthly Movement

5 Feb 2019 07:00

RNS Number : 0381P
Kore Potash PLC
05 February 2019
Β 

5 February 2019

Β 

Kore Potash Plc

("Kore Potash" or the "Company")

CDI Monthly Movement

Β 

Kore Potash plc advises the following movements in CDIs over its ordinary shares during January 2019:

Β 

Balance - 31 December 2018

250,591,732

Net Movement *

(19,404,978)

Balance - 31 January 2019

231,186,754)

Β 

* Increase/(Decrease) in the number of CDIs quoted on ASX as a result of transfers between CDIs quoted on ASX and ordinary shares quoted on AIM and JSE, as required by the ASX to be reported on a monthly basis.

Β 

A copy of the Appendix 3B lodged with the ASX reflecting the movement is attached below.

Β 

Β 

Β 

ENDS

Β 

For further information, please visit www.korepotash.com or contact:

Β 

Β 

Kore Potash

Brad Sampson - CEO

Β 

Tel: +27 11 469 9140

Tavistock Communications

Jos Simson

Edward Lee

Β 

Tel: +44 (0) 20 7920 3150

Canaccord Genuity - Nomad and Broker

Martin Davison

James Asensio

Β 

Tel: +44 (0) 20 7523 4600

Β 

Β 

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

Β 

New issue announcement,

application for quotation of additional securities

and agreement

Β 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Β 

Β 

Name of entity

Kore Potash plc (ASX: KP2)

Β 

ARBN

621 843 614

Β 

We (the entity) give ASX the following information.

Β 

Β 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

Β 

1

+Class of +securities issued or to be issued

Β 

CHESS Depositary Interests corresponding to fully paid ordinary shares (CDIs)

Β 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

Β 

CDIs:

Β 

As at 31 December 2018

250,591,732

Net transfers *

(19,404,978)

As at 31 January 2019

231,186,754

Β 

* Transfers between CDIs quoted on ASX and ordinary shares quoted on AIM and JSE

Β 

3

Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

Increase/(Decrease) in the number of CDIs quoted on ASX as a result of transfers between CDIs quoted on ASX and ordinary shares quoted on AIM and JSE, as required to be reported on a monthly basis.

Β 

4

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

Β 

If the additional +securities do not rank equally, please state:

Β· the date from which they do

Β· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

Β· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Yes

Β 

5

Issue price or consideration

Β 

Nil

Β 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

Β 

Notification to ASX of the movement of CDIs quoted on ASX and ordinary shares quoted on AIM and JSE

Β 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

Β 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

No

Β 

6b

The date the security holder resolution under rule 7.1A was passed

N/A

Β 

6c

Number of +securities issued without security holder approval under rule 7.1

N/A

Β 

6d

Number of +securities issued with security holder approval under rule 7.1A

N/A

Β 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

Β 

N/A

Β 

6f

Number of +securities issued under an exception in rule 7.2

N/A

Β 

6g

If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.

N/A

Β 

6h

If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

N/A

Β 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

N/A

7

+Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

Movements during January 2019

Β 

Β 

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable)

231,186,754

Chess Depository Interests at a ratio of 1 CDI representing 1 fully paid ordinary share as issued on the ASX (noting that an additional 629,665,939 ordinary shares are at 31 January 2019 quoted on either the AIM market of the London Stock Exchange or the Johannesburg Stock Exchange).

Β 

Β 

Number

+Class

9

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable)

Β 

50,000,000

Β 

Β 

1,886,996

Β 

Β 

2,255,000

Β 

Β 

5,881,250

Β 

Β 

660,000

Β 

Β 

Β 

1,405,000

Β 

Β 

3,747,005

Β 

Β 

11,734,853

Β 

Β 

13,144,659

Β 

Β 

4,500,000

Β 

Β 

4,000,000

Β 

Β 

17,200,000

Β 

Unlisted Options exercisable at AUD 0.30 each expiring 15 Nov 2019

Β 

Class C Performance Rights each expiring 16 September 2019 (Emp)

Β 

Performance Rights expiring 6 December 2020 (Emp)

Β 

Performance Rights expiring 1 March 2021 (Dir)

Β 

Performance Rights vesting on 31 May 2019 (Dir)

Β 

Β 

Performance Shares vesting on 31 May 2019

Β 

Performance Shares under a Short Term Incentive Scheme Plan for 2017

Β 

Performance Shares under the Long Term Incentive Plan

Β 

Equity Warrants exercisable at A$0.30 each expiring 29 March 2021

Β 

Performance Rights expiring 22 May 2022 (Dir)

Β 

Unlisted Options exercisable at Β£0.11 each expiring on 27 June 2020

Β 

Unlisted Options exercisable at Β£0.11 each expiring on 27 June 2028

Β 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

N/A

Β 

Part 2 ‑ Bonus issue or pro rata issue

Β 

11

Is security holder approval required?

N/A

12

Is the issue renounceable or non-renounceable?

N/A

13

Ratio in which the +securities will be offered

N/A

14

+Class of +securities to which the offer relates

N/A

15

+Record date to determine entitlements

N/A

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

N/A

17

Policy for deciding entitlements in relation to fractions

N/A

18

Names of countries in which the entity has security holders who will not be sent new offer documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

N/A

19

Closing date for receipt of acceptances or renunciations

N/A

20

Names of any underwriters

N/A

21

Amount of any underwriting fee or commission

N/A

22

Names of any brokers to the issue

N/A

23

Fee or commission payable to the broker to the issue

N/A

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders

N/A

25

If the issue is contingent on +security holders' approval, the date of the meeting

N/A

26

Date entitlement and acceptance form and will be sent to persons entitled

N/A

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

N/A

28

Date rights trading will begin (if applicable)

N/A

29

Date rights trading will end (if applicable)

N/A

30

How do security holders sell their entitlements in full through a broker?

N/A

31

How do security holders sell part of their entitlements through a broker and accept for the balance?

N/A

Β 

32

How do security holders dispose of their entitlements (except by sale through a broker)?

N/A

33

+Issue date

N/A

Β 

Β 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

Β 

34

Type of securities

(tick one)

Β 

(a)

+Securities described in Part 1

Β 

(b)

All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Β 

Entities that have ticked box 34(a)

Β Additional securities forming a new class of securities

Β 

Β 

Tick to indicate you are providing the information or documents

Β 

35

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

36

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

37

A copy of any trust deed for the additional +securities

Β 

Entities that have ticked box 34(b)

Β 

38

Number of +securities for which +quotation is sought

Β 

Β 

Β 

39

Class of +securities for which quotation is sought

Β 

Β 

Β 

40

Do the +securities rank equally in all respects from the +issue with an existing +class of quoted +securities?

Β 

If the additional +securities do not rank equally, please state:

Β· the date from which they do

Β· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

Β· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Β 

Β 

41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

Β 

(if issued upon conversion of another +security, clearly identify that other +security)

Β 

Β 

Β 

Number

+Class

42

Number and +class of all +securities quoted on ASX (including the +securities in clause 38)

Β 

Β 

Β 

Β 

Β 

Β 

Quotation agreement

Β 

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

Β 

2 We warrant the following to ASX.

Β 

Β· The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

Β 

Β· There is no reason why those +securities should not be granted +quotation.

Β 

Β· An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

Β 

Β· Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

Β 

Β· If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

Β 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

Β 

4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Β 

Β 

[ signed electronically ]

Sign here: ............................................................Date: 5 February 2019

Joint Company Secretary

Β 

Print name: Henko Vos

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
MSCDZLFBKLFXBBQ
Date   Source Headline
3rd Sep 20198:00 amRNSCDI Monthly Movement
30th Aug 20198:00 amRNSAppointment of CFO
7th Aug 201910:00 amRNSCDI Monthly Movement
31st Jul 20197:00 amRNSReview of Operations for Q2 2019
29th Jul 20197:00 amRNSKola capex optimisation update
19th Jul 201910:04 amRNSDirector/ PDMR Shareholdings
19th Jul 201910:03 amRNSDirector/ PDMR Shareholdings
19th Jul 201910:02 amRNSDirector/ PDMR Shareholdings
19th Jul 201910:01 amRNSNotice Under Section 708A
19th Jul 201910:00 amRNSAppendix 3B
17th Jul 201911:00 amRNSResults of General Meeting and Issue of Shares
10th Jul 201910:00 amRNSCorrection to Notice of General Meeting
5th Jul 201910:16 amRNSCDI Monthly Movement
2nd Jul 20197:00 amRNSDirector/PDMR Shareholding
2nd Jul 20197:00 amRNSDirector/PDMR Shareholding
28th Jun 201910:16 amRNSNotice of GM
28th Jun 201910:15 amRNSResult of AGM
25th Jun 20194:45 pmRNSRemote access to AGM
21st Jun 20197:00 amRNSPerformance Rights
14th Jun 201911:05 amRNSSecond Price Monitoring Extn
14th Jun 201911:00 amRNSPrice Monitoring Extension
14th Jun 20197:58 amRNSResults of Placing and Subscription
13th Jun 20194:45 pmRNSProposed Fundraise to raise approx US$13m
5th Jun 20197:00 amRNSCDI Monthly Movement
5th Jun 20197:00 amRNSNotice of AGM and Directorate Changes
7th May 20197:00 amRNSCDI Monthly Movement
29th Apr 20198:00 amRNSReview of Operations for Q1 2019
29th Apr 20197:00 amRNSDougou Extension Solution Mining Scoping Study
15th Apr 20199:41 amRNSPerformance Rights
2nd Apr 20197:00 amRNSCDI Monthly Movement
29th Mar 20194:41 pmRNSSecond Price Monitoring Extn
29th Mar 20194:36 pmRNSPrice Monitoring Extension
29th Mar 201910:15 amRNSFINANCIAL REPORT FOR YEAR ENDED 31 DECEMBER 2018
26th Mar 20197:00 amRNSEPC Received
6th Mar 20197:00 amRNSCDI Monthly Movement
14th Feb 20197:32 amRNSDirector/PDMR Shareholding
14th Feb 20197:31 amRNSIssue of Equity
14th Feb 20197:30 amRNSCDI Movement
5th Feb 20197:00 amRNSCDI Monthly Movement
31st Jan 20199:00 amRNSCashflow Report for Q4 2018
31st Jan 20199:00 amRNSReview of Operations for Q4 2018
30th Jan 20192:05 pmRNSSecond Price Monitoring Extn
30th Jan 20192:00 pmRNSPrice Monitoring Extension
29th Jan 20197:00 amRNSKola Definitive Feasibility Study
8th Jan 20197:00 amRNSCDI Monthly Movement
7th Dec 20188:50 amRNSMining Convention passed into Law
5th Dec 20187:00 amRNSCDI Monthly Movement
21st Nov 20187:00 amRNSExtensions to Sylvinite Deposits Expected
16th Nov 201811:06 amRNSSecond Price Monitoring Extn
16th Nov 201811:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.